AlzChem Group（ACT）株式概要アルツケムグループAGは、その子会社とともに、ドイツ、欧州連合、その他の欧州諸国、アジア、NAFTA地域、および国際的に、さまざまな化学特殊製品を開発、生産、販売している。 詳細ACT ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長4/6過去の実績4/6財務の健全性5/6配当金1/6報酬当社が推定した公正価値より56.7%で取引されている 収益は年間19.07%増加すると予測されています 過去1年間で収益は18.3%増加しました リスク分析高いレベルの非現金収入 すべてのリスクチェックを見るACT Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€163.4023.2% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture0988m2016201920222025202620282031Revenue €987.7mEarnings €113.6mAdvancedSet Fair ValueView all narrativesAlzChem Group AG 競合他社Uzin UtzSymbol: XTRA:UZUMarket cap: €322.8mEvonik IndustriesSymbol: XTRA:EVKMarket cap: €8.0bSymriseSymbol: XTRA:SY1Market cap: €11.0bNabaltecSymbol: XTRA:NTGMarket cap: €99.9m価格と性能株価の高値、安値、推移の概要AlzChem Group過去の株価現在の株価€163.4052週高値€188.8052週安値€117.20ベータ0.371ヶ月の変化-11.87%3ヶ月変化3.42%1年変化36.17%3年間の変化773.80%5年間の変化564.23%IPOからの変化507.66%最新ニュースお知らせ • Mar 25AlzChem Group AG, Annual General Meeting, May 05, 2026AlzChem Group AG, Annual General Meeting, May 05, 2026, at 10:00 W. Europe Standard Time.お知らせ • Feb 28AlzChem Group AG announces Annual dividend, payable on May 08, 2026AlzChem Group AG announced Annual dividend of EUR 2.1000 per share payable on May 08, 2026, ex-date on May 06, 2026 and record date on May 07, 2026.お知らせ • Nov 06+ 3 more updatesAlzChem Group AG to Report Q3, 2026 Results on Oct 30, 2026AlzChem Group AG announced that they will report Q3, 2026 results on Oct 30, 2026お知らせ • Sep 24AlzChem Group AG to Report Q3, 2025 Results on Oct 30, 2025AlzChem Group AG announced that they will report Q3, 2025 results on Oct 30, 2025お知らせ • May 09AlzChem Group AG to Report First Half, 2025 Results on Jul 30, 2025AlzChem Group AG announced that they will report first half, 2025 results on Jul 30, 2025お知らせ • May 02AlzChem Group AG Confirms Earnings Guidance for the Fiscal Year 2025AlzChem Group AG confirmed earnings guidance for the fiscal year 2025. For the year, the Group sales are expected to grow by approximately 5% compared with the previous year.最新情報をもっと見るRecent updatesお知らせ • Mar 25AlzChem Group AG, Annual General Meeting, May 05, 2026AlzChem Group AG, Annual General Meeting, May 05, 2026, at 10:00 W. Europe Standard Time.お知らせ • Feb 28AlzChem Group AG announces Annual dividend, payable on May 08, 2026AlzChem Group AG announced Annual dividend of EUR 2.1000 per share payable on May 08, 2026, ex-date on May 06, 2026 and record date on May 07, 2026.お知らせ • Nov 06+ 3 more updatesAlzChem Group AG to Report Q3, 2026 Results on Oct 30, 2026AlzChem Group AG announced that they will report Q3, 2026 results on Oct 30, 2026お知らせ • Sep 24AlzChem Group AG to Report Q3, 2025 Results on Oct 30, 2025AlzChem Group AG announced that they will report Q3, 2025 results on Oct 30, 2025お知らせ • May 09AlzChem Group AG to Report First Half, 2025 Results on Jul 30, 2025AlzChem Group AG announced that they will report first half, 2025 results on Jul 30, 2025お知らせ • May 02AlzChem Group AG Confirms Earnings Guidance for the Fiscal Year 2025AlzChem Group AG confirmed earnings guidance for the fiscal year 2025. For the year, the Group sales are expected to grow by approximately 5% compared with the previous year.お知らせ • Mar 29AlzChem Group AG, Annual General Meeting, May 08, 2025AlzChem Group AG, Annual General Meeting, May 08, 2025, at 10:00 W. Europe Standard Time.お知らせ • Dec 06Alzchem Group Ag Appoints Martina Spitzer as A New Member of the Management Board, Effective from January 1, 2025AlzChem Group AG approved the appointment of Martina Spitzer as a new member of the Management Board for a term of three years from January 1, 2025 to December 31, 2027. In her new position as Chief Sales Officer (CSO), she will be responsible for the areas of Health & Nutrition (Creapure®), Fine Chemicals (Chemicals & Applications) and Sustainability (ESG). Ms. Spitzer’s appointment as CSO represents the next important step in the early succession planning for the Management Board. Ms. Spitzer is now already taking over two important business areas in sales, as Dr. Weichselbaumer will be in charge of the future project of setting up production in the USA. Ms. Spitzer has been with the Alzchem Group since 1999. In 2020, she was appointed Head of Alzchem’s entire chemical sales division, before she shifted her focus to strategic corporate development and ESG in 2022 after around 15 years in sales. In this role, she was instrumental in the introduction of the sustainability division, the optimization of central business processes and the implementation of forward-looking projects.お知らせ • Nov 27AlzChem Group AG to Report Q1, 2025 Results on Apr 30, 2025AlzChem Group AG announced that they will report Q1, 2025 results on Apr 30, 2025Reported Earnings • Nov 09Third quarter 2024 earnings released: EPS: €1.22 (vs €0.85 in 3Q 2023)Third quarter 2024 results: EPS: €1.22 (up from €0.85 in 3Q 2023). Revenue: €132.7m (up 7.0% from 3Q 2023). Net income: €12.4m (up 44% from 3Q 2023). Profit margin: 9.3% (up from 7.0% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 08AlzChem Group AG to Report Fiscal Year 2024 Results on Feb 28, 2025AlzChem Group AG announced that they will report fiscal year 2024 results on Feb 28, 2025Price Target Changed • Oct 23Price target increased by 13% to €71.78Up from €63.65, the current price target is an average from 4 analysts. New target price is 24% above last closing price of €57.80. Stock is up 196% over the past year. The company is forecast to post earnings per share of €4.97 for next year compared to €3.40 last year.Price Target Changed • Oct 11Price target increased by 7.7% to €66.03Up from €61.30, the current price target is an average from 4 analysts. New target price is 22% above last closing price of €54.20. Stock is up 170% over the past year. The company is forecast to post earnings per share of €4.92 for next year compared to €3.40 last year.Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €52.40, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 150% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.85 per share.Buy Or Sell Opportunity • Sep 30Now 23% overvaluedOver the last 90 days, the stock has fallen 1.9% to €47.30. The fair value is estimated to be €38.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 10% in 2 years. Earnings are forecast to grow by 23% in the next 2 years.Valuation Update With 7 Day Price Move • Sep 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €41.50, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 91% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.38 per share.Price Target Changed • Aug 19Price target increased by 13% to €61.30Up from €54.05, the current price target is an average from 4 analysts. New target price is 18% above last closing price of €52.00. Stock is up 154% over the past year. The company is forecast to post earnings per share of €4.93 for next year compared to €3.40 last year.Price Target Changed • Aug 06Price target increased by 7.5% to €56.05Up from €52.15, the current price target is an average from 4 analysts. New target price is 21% above last closing price of €46.30. Stock is up 148% over the past year. The company is forecast to post earnings per share of €4.52 for next year compared to €3.40 last year.Reported Earnings • Aug 02Second quarter 2024 earnings released: EPS: €0.71 (vs €0.70 in 2Q 2023)Second quarter 2024 results: EPS: €0.71 (up from €0.70 in 2Q 2023). Revenue: €139.9m (up 5.2% from 2Q 2023). Net income: €14.4m (up 100% from 2Q 2023). Profit margin: 10% (up from 5.4% in 2Q 2023). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 02AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024AlzChem Group AG announced that they will report Q3, 2024 results on Nov 07, 2024Price Target Changed • Jul 30Price target increased by 9.4% to €54.05Up from €49.40, the current price target is an average from 4 analysts. New target price is 9.2% above last closing price of €49.50. Stock is up 159% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €3.40 last year.New Risk • Jul 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.0% average weekly change).Price Target Changed • May 15Price target increased by 15% to €49.40Up from €43.10, the current price target is an average from 4 analysts. New target price is 12% above last closing price of €44.00. Stock is up 122% over the past year. The company is forecast to post earnings per share of €4.03 for next year compared to €3.40 last year.お知らせ • May 09AlzChem Group AG to Report First Half, 2024 Results on Aug 01, 2024AlzChem Group AG announced that they will report first half, 2024 results on Aug 01, 2024Reported Earnings • May 01First quarter 2024 earnings released: EPS: €1.20 (vs €0.76 in 1Q 2023)First quarter 2024 results: EPS: €1.20 (up from €0.76 in 1Q 2023). Revenue: €153.6m (up 1.4% from 1Q 2023). Net income: €12.2m (up 59% from 1Q 2023). Profit margin: 7.9% (up from 5.1% in 1Q 2023). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €43.50, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 101% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.69 per share.Declared Dividend • Mar 28Dividend increased to €1.20Dividend of €1.20 is 14% higher than last year. Ex-date: 8th May 2024 Payment date: 10th May 2024 Dividend yield will be 3.2%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (35% earnings payout ratio) and cash flows (23% cash payout ratio). The dividend has increased by an average of 1.5% per year over the past 6 years. However, payments have been volatile during that time. EPS is expected to grow by 40% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Price Target Changed • Mar 07Price target increased by 7.9% to €37.35Up from €34.63, the current price target is an average from 4 analysts. New target price is 25% above last closing price of €30.00. Stock is up 60% over the past year. The company is forecast to post earnings per share of €3.83 for next year compared to €3.40 last year.Price Target Changed • Mar 04Price target increased by 7.9% to €35.60Up from €33.00, the current price target is an average from 4 analysts. New target price is 31% above last closing price of €27.10. Stock is up 38% over the past year. The company is forecast to post earnings per share of €3.77 for next year compared to €3.40 last year.Price Target Changed • Dec 05Price target increased by 9.1% to €34.63Up from €31.75, the current price target is an average from 4 analysts. New target price is 40% above last closing price of €24.70. Stock is up 36% over the past year. The company is forecast to post earnings per share of €3.51 for next year compared to €2.96 last year.お知らせ • Nov 30AlzChem Group AG to Report Q1, 2024 Results on Apr 30, 2024AlzChem Group AG announced that they will report Q1, 2024 results on Apr 30, 2024Price Target Changed • Nov 10Price target increased by 9.3% to €33.00Up from €30.20, the current price target is an average from 4 analysts. New target price is 42% above last closing price of €23.30. Stock is up 40% over the past year. The company is forecast to post earnings per share of €3.31 for next year compared to €2.96 last year.New Risk • Oct 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.5% average weekly change).Reported Earnings • Oct 29Third quarter 2023 earnings released: EPS: €0.85 (vs €0.58 in 3Q 2022)Third quarter 2023 results: EPS: €0.85 (up from €0.58 in 3Q 2022). Revenue: €123.9m (down 15% from 3Q 2022). Net income: €8.61m (up 45% from 3Q 2022). Profit margin: 7.0% (up from 4.1% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 27AlzChem Group AG to Report Fiscal Year 2023 Results on Mar 01, 2024AlzChem Group AG announced that they will report fiscal year 2023 results on Mar 01, 2024お知らせ • Sep 19AlzChem Group AG to Report Q3, 2023 Results on Oct 26, 2023AlzChem Group AG announced that they will report Q3, 2023 results on Oct 26, 2023Valuation Update With 7 Day Price Move • Aug 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €22.00, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in Germany. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.19 per share.New Risk • Aug 04New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 42% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (42% net debt to equity). Dividend is not well covered by cash flows (138% cash payout ratio).Reported Earnings • Aug 03Second quarter 2023 earnings released: EPS: €0.71 (vs €0.95 in 2Q 2022)Second quarter 2023 results: EPS: €0.71 (down from €0.95 in 2Q 2022). Revenue: €128.5m (down 14% from 2Q 2022). Net income: €7.20m (down 25% from 2Q 2022). Profit margin: 5.6% (down from 6.5% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • May 06First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: EPS: €0.76 (down from €0.76 in 1Q 2022). Revenue: €156.0m (up 19% from 1Q 2022). Net income: €7.67m (flat on 1Q 2022). Profit margin: 4.9% (down from 5.9% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.1%. Earnings per share (EPS) also surpassed analyst estimates by 23%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.お知らせ • May 05AlzChem Group AG to Report First Half, 2023 Results on Aug 03, 2023AlzChem Group AG announced that they will report first half, 2023 results on Aug 03, 2023Upcoming Dividend • May 05Upcoming dividend of €1.05 per share at 5.5% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. Payout ratio is a comfortable 35% but the company is not cash flow positive. Trailing yield: 5.5%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).Price Target Changed • Mar 21Price target increased by 8.7% to €29.58Up from €27.20, the current price target is an average from 4 analysts. New target price is 57% above last closing price of €18.85. Stock is down 21% over the past year. The company posted earnings per share of €2.96 last year.Reported Earnings • Mar 01Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €2.96 (up from €2.72 in FY 2021). Revenue: €566.4m (up 32% from FY 2021). Net income: €30.1m (up 8.9% from FY 2021). Profit margin: 5.3% (down from 6.4% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to €17.85, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 12x in the Chemicals industry in Germany. Total loss to shareholders of 10% over the past three years.お知らせ • Dec 09AlzChem Group AG, Annual General Meeting, May 11, 2023AlzChem Group AG, Annual General Meeting, May 11, 2023, at 10:00 Central European Standard Time.Price Target Changed • Nov 16Price target decreased to €26.05Down from €29.43, the current price target is an average from 4 analysts. New target price is 55% above last closing price of €16.85. Stock is down 28% over the past year. The company is forecast to post earnings per share of €2.40 for next year compared to €2.72 last year.Reported Earnings • Oct 28Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: €0.59 (up from €0.46 in 3Q 2021). Revenue: €145.1m (up 48% from 3Q 2021). Net income: €5.93m (up 27% from 3Q 2021). Profit margin: 4.1% (down from 4.8% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 18%. Earnings per share (EPS) also surpassed analyst estimates by 69%. Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.お知らせ • Oct 27AlzChem Group AG to Report Fiscal Year 2022 Final Results on Feb 28, 2023AlzChem Group AG announced that they will report fiscal year 2022 final results at 9:00 AM, Central European Standard Time on Feb 28, 2023Price Target Changed • Oct 20Price target decreased to €26.05Down from €29.43, the current price target is an average from 4 analysts. New target price is 73% above last closing price of €15.05. Stock is down 33% over the past year. The company is forecast to post earnings per share of €2.55 for next year compared to €2.72 last year.Reported Earnings • Jul 27Second quarter 2022 earnings released: EPS: €0.95 (vs €0.90 in 2Q 2021)Second quarter 2022 results: EPS: €0.95 (up from €0.90 in 2Q 2021). Revenue: €142.4m (up 26% from 2Q 2021). Net income: €9.59m (up 4.5% from 2Q 2021). Profit margin: 6.7% (down from 8.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 8.7%, compared to a 7.3% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • May 11First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.76 (down from €0.78 in 1Q 2021). Revenue: €133.5m (up 25% from 1Q 2021). Net income: €7.70m (down 2.4% from 1Q 2021). Profit margin: 5.8% (down from 7.4% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 9.9%. Over the next year, revenue is forecast to grow 8.7%, compared to a 6.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Upcoming Dividend • Apr 29Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 06 May 2022. Payment date: 10 May 2022. Payout ratio is a comfortable 37% and this is well supported by cash flows. Trailing yield: 4.5%. Within top quartile of German dividend payers (4.0%). In line with average of industry peers (4.9%).Reported Earnings • Feb 25Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: €2.72 (up from €1.94 in FY 2020). Revenue: €433.7m (up 12% from FY 2020). Net income: €27.6m (up 40% from FY 2020). Profit margin: 6.4% (up from 5.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 4.1%, compared to a 6.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS €0.46 (vs €0.37 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €98.1m (up 17% from 3Q 2020). Net income: €4.69m (up 25% from 3Q 2020). Profit margin: 4.8% (up from 4.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Price Target Changed • Aug 09Price target increased to €32.25Up from €28.50, the current price target is an average from 2 analysts. New target price is 31% above last closing price of €24.70. Stock is up 23% over the past year.Reported Earnings • Aug 06Second quarter 2021 earnings released: EPS €0.66 (vs €0.66 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €113.5m (up 6.5% from 2Q 2020). Net income: €9.17m (up 37% from 2Q 2020). Profit margin: 8.1% (up from 6.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year and the company’s share price has also fallen by 6% per year.Reported Earnings • May 07First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €108.3m (up 13% from 1Q 2020). Net income: €7.89m (up 80% from 1Q 2020). Profit margin: 7.3% (up from 4.6% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Upcoming Dividend • May 06Upcoming dividend of €0.77 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 18 May 2021. Trailing yield: 3.1%. Within top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).Reported Earnings • Mar 20Full year 2020 earnings released: EPS €1.94 (vs €1.77 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €389.9m (up 1.3% from FY 2019). Net income: €19.7m (up 9.6% from FY 2019). Profit margin: 5.1% (up from 4.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Feb 25New 90-day high: €24.50The company is up 19% from its price of €20.60 on 27 November 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €43.68 per share.お知らせ • Jan 16AlzChem Group AG to Report Fiscal Year 2020 Results on Mar 19, 2021AlzChem Group AG announced that they will report fiscal year 2020 results on Mar 19, 2021Analyst Estimate Surprise Post Earnings • Nov 12Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 16%. Over the next year, revenue is forecast to grow 4.9%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.Reported Earnings • Nov 12Third quarter 2020 earnings released: EPS €0.37The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: €84.1m (down 18% from 3Q 2019). Net income: €3.76m (down 25% from 3Q 2019). Profit margin: 4.5% (down from 4.9% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 78% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.お知らせ • Nov 07AlzChem Group AG Expands Nitrile Production by 50%AlzChem Group AG consistently continues its growth and investment strategy even in the current environment. Due to the continuing high level of market demand, nitrile production will be expanded by up to 50% by the second quarter of 2021. The investment volume amounts to approximately EUR 12 million. The currently available capacities had only been expanded as of July 2019 and quickly reached 100% capacity. The additional nitrile production capacities are intended to primarily support the growth of medications and biocides. AlzChem takes advantage of the market trend towards more robust supply chains, thus following the trend of increased supply security through a European supplier. The expanded nitrile production plant is again based on AlzChem's proven gas phase technology, which is continuously being optimized by AlzChem engineers and chemists and which sets the standards in terms of raw material yield and environmental aspects.Is New 90 Day High Low • Oct 30New 90-day low: €17.50The company is down 4.0% from its price of €18.15 on 31 July 2020. The German market is also down 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.80 per share.お知らせ • Oct 15AlzChem Group AG Revises Consolidated Sales Guidance for the Fiscal Year 2020AlzChem Group AG revised consolidated sales guidance for the fiscal year 2020. Due to the continuing economic effects of the COVID-19 pandemic in individual target industries and regions, AlzChem Group AG adjusts its forecast for fiscal year 2020. The company now expects to generate stable to slightly declining consolidated sales compared to the previous year (original forecast: slightly rising to sharply rising).お知らせ • Oct 01+ 1 more updateAlzChem Group AG to Report First Half, 2021 Results on Aug 05, 2021AlzChem Group AG announced that they will report first half, 2021 results on Aug 05, 2021お知らせ • Sep 12AlzChem Group AG to Report Q1, 2021 Results on May 06, 2021AlzChem Group AG announced that they will report Q1, 2021 results on May 06, 2021株主還元ACTDE ChemicalsDE 市場7D-2.0%-0.3%3.2%1Y36.2%5.7%2.5%株主還元を見る業界別リターン: ACT過去 1 年間で5.7 % の収益を上げたGerman Chemicals業界を上回りました。リターン対市場: ACT過去 1 年間で2.5 % の収益を上げたGerman市場を上回りました。価格変動Is ACT's price volatile compared to industry and market?ACT volatilityACT Average Weekly Movement6.9%Chemicals Industry Average Movement6.0%Market Average Movement6.1%10% most volatile stocks in DE Market13.6%10% least volatile stocks in DE Market2.7%安定した株価: ACT 、 German市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: ACTの 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19081,680Andreas Niedermaierwww.alzchem.comアルツケムグループAGは、その子会社とともに、ドイツ、欧州連合、欧州以外の地域、アジア、NAFTA地域、および国際的に、さまざまな化学特殊製品の開発、生産、販売を行っている。同社は3つのセグメントで事業を展開している：特殊化学品事業、基礎・中間体事業、その他・持株事業である。特殊化学品部門は、化学、食品、飼料、防衛技術、再生可能エネルギー産業で使用される特殊化学品を販売している。このセグメントでは、複合材料や接着剤、セラミック用窒化ケイ素、太陽電池モジュールなどを製造している。基礎・中間体部門は、特殊化学品原料、農業・冶金用製品、石灰、炭素、電力から製造される化学工業用中間体を製造している。また、農薬・医薬原体原料としてのグアニジン塩の製造・販売も行っている。その他・持株事業では、ケミカルパークの運営・管理サービス、各種インフラサービスの製造・販売を行っている。農業分野では「CALCIUM CYANAMIDE PERLKA」、「EMINEX」、「DORMEX」、「ALZOGUR」、「SITOFEX」、「BREAK-THRU」ブランド、動物栄養分野では「CREAMINO」ブランド、人間栄養分野では「CREAPURE」、「CREAVITALIS」、「LIVADUR」、「ALIPURE」ブランド、医薬品分野では「GUANIDINE SALTS - BIOSELECT」ブランドで製品とサービスを提供している；GUANIDINSALZE -BIOSELECT」、「CYANAMIDE」、「DICYANDIAMIDE」、「GUANAMINE」、「NITRILES」、「MELFLOCK」、「ALZOFIX」、「THIOUREA」、「NITROGUANIDINE」ブランドのファインケミカル部門、「CAD」、「CALCIPRO」、「CALZOT」ブランドの冶金部門、「テクニカルガス」、「炭化カルシウム」、「DYHARD」、「SILZOT」ブランドの再生可能エネルギー部門、受託微粉化や製造などのカスタム合成部門。同社は1908年に設立され、ドイツのトロストベルクに本社を置いている。もっと見るAlzChem Group AG 基礎のまとめAlzChem Group の収益と売上を時価総額と比較するとどうか。ACT 基礎統計学時価総額€1.68b収益（TTM）€66.82m売上高(TTM)€581.10m25.1xPER（株価収益率2.9xP/SレシオACT は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計ACT 損益計算書（TTM）収益€581.10m売上原価€195.25m売上総利益€385.85mその他の費用€319.03m収益€66.82m直近の収益報告Mar 31, 2026次回決算日Jul 30, 2026一株当たり利益（EPS）6.60グロス・マージン66.40%純利益率11.50%有利子負債／自己資本比率14.3%ACT の長期的なパフォーマンスは？過去の実績と比較を見る配当金1.3%現在の配当利回り33%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 23:48終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋AlzChem Group AG 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchGerhard OrgonasBerenberg5 その他のアナリストを表示
お知らせ • Mar 25AlzChem Group AG, Annual General Meeting, May 05, 2026AlzChem Group AG, Annual General Meeting, May 05, 2026, at 10:00 W. Europe Standard Time.
お知らせ • Feb 28AlzChem Group AG announces Annual dividend, payable on May 08, 2026AlzChem Group AG announced Annual dividend of EUR 2.1000 per share payable on May 08, 2026, ex-date on May 06, 2026 and record date on May 07, 2026.
お知らせ • Nov 06+ 3 more updatesAlzChem Group AG to Report Q3, 2026 Results on Oct 30, 2026AlzChem Group AG announced that they will report Q3, 2026 results on Oct 30, 2026
お知らせ • Sep 24AlzChem Group AG to Report Q3, 2025 Results on Oct 30, 2025AlzChem Group AG announced that they will report Q3, 2025 results on Oct 30, 2025
お知らせ • May 09AlzChem Group AG to Report First Half, 2025 Results on Jul 30, 2025AlzChem Group AG announced that they will report first half, 2025 results on Jul 30, 2025
お知らせ • May 02AlzChem Group AG Confirms Earnings Guidance for the Fiscal Year 2025AlzChem Group AG confirmed earnings guidance for the fiscal year 2025. For the year, the Group sales are expected to grow by approximately 5% compared with the previous year.
お知らせ • Mar 25AlzChem Group AG, Annual General Meeting, May 05, 2026AlzChem Group AG, Annual General Meeting, May 05, 2026, at 10:00 W. Europe Standard Time.
お知らせ • Feb 28AlzChem Group AG announces Annual dividend, payable on May 08, 2026AlzChem Group AG announced Annual dividend of EUR 2.1000 per share payable on May 08, 2026, ex-date on May 06, 2026 and record date on May 07, 2026.
お知らせ • Nov 06+ 3 more updatesAlzChem Group AG to Report Q3, 2026 Results on Oct 30, 2026AlzChem Group AG announced that they will report Q3, 2026 results on Oct 30, 2026
お知らせ • Sep 24AlzChem Group AG to Report Q3, 2025 Results on Oct 30, 2025AlzChem Group AG announced that they will report Q3, 2025 results on Oct 30, 2025
お知らせ • May 09AlzChem Group AG to Report First Half, 2025 Results on Jul 30, 2025AlzChem Group AG announced that they will report first half, 2025 results on Jul 30, 2025
お知らせ • May 02AlzChem Group AG Confirms Earnings Guidance for the Fiscal Year 2025AlzChem Group AG confirmed earnings guidance for the fiscal year 2025. For the year, the Group sales are expected to grow by approximately 5% compared with the previous year.
お知らせ • Mar 29AlzChem Group AG, Annual General Meeting, May 08, 2025AlzChem Group AG, Annual General Meeting, May 08, 2025, at 10:00 W. Europe Standard Time.
お知らせ • Dec 06Alzchem Group Ag Appoints Martina Spitzer as A New Member of the Management Board, Effective from January 1, 2025AlzChem Group AG approved the appointment of Martina Spitzer as a new member of the Management Board for a term of three years from January 1, 2025 to December 31, 2027. In her new position as Chief Sales Officer (CSO), she will be responsible for the areas of Health & Nutrition (Creapure®), Fine Chemicals (Chemicals & Applications) and Sustainability (ESG). Ms. Spitzer’s appointment as CSO represents the next important step in the early succession planning for the Management Board. Ms. Spitzer is now already taking over two important business areas in sales, as Dr. Weichselbaumer will be in charge of the future project of setting up production in the USA. Ms. Spitzer has been with the Alzchem Group since 1999. In 2020, she was appointed Head of Alzchem’s entire chemical sales division, before she shifted her focus to strategic corporate development and ESG in 2022 after around 15 years in sales. In this role, she was instrumental in the introduction of the sustainability division, the optimization of central business processes and the implementation of forward-looking projects.
お知らせ • Nov 27AlzChem Group AG to Report Q1, 2025 Results on Apr 30, 2025AlzChem Group AG announced that they will report Q1, 2025 results on Apr 30, 2025
Reported Earnings • Nov 09Third quarter 2024 earnings released: EPS: €1.22 (vs €0.85 in 3Q 2023)Third quarter 2024 results: EPS: €1.22 (up from €0.85 in 3Q 2023). Revenue: €132.7m (up 7.0% from 3Q 2023). Net income: €12.4m (up 44% from 3Q 2023). Profit margin: 9.3% (up from 7.0% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 08AlzChem Group AG to Report Fiscal Year 2024 Results on Feb 28, 2025AlzChem Group AG announced that they will report fiscal year 2024 results on Feb 28, 2025
Price Target Changed • Oct 23Price target increased by 13% to €71.78Up from €63.65, the current price target is an average from 4 analysts. New target price is 24% above last closing price of €57.80. Stock is up 196% over the past year. The company is forecast to post earnings per share of €4.97 for next year compared to €3.40 last year.
Price Target Changed • Oct 11Price target increased by 7.7% to €66.03Up from €61.30, the current price target is an average from 4 analysts. New target price is 22% above last closing price of €54.20. Stock is up 170% over the past year. The company is forecast to post earnings per share of €4.92 for next year compared to €3.40 last year.
Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €52.40, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 150% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.85 per share.
Buy Or Sell Opportunity • Sep 30Now 23% overvaluedOver the last 90 days, the stock has fallen 1.9% to €47.30. The fair value is estimated to be €38.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 10% in 2 years. Earnings are forecast to grow by 23% in the next 2 years.
Valuation Update With 7 Day Price Move • Sep 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €41.50, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 91% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.38 per share.
Price Target Changed • Aug 19Price target increased by 13% to €61.30Up from €54.05, the current price target is an average from 4 analysts. New target price is 18% above last closing price of €52.00. Stock is up 154% over the past year. The company is forecast to post earnings per share of €4.93 for next year compared to €3.40 last year.
Price Target Changed • Aug 06Price target increased by 7.5% to €56.05Up from €52.15, the current price target is an average from 4 analysts. New target price is 21% above last closing price of €46.30. Stock is up 148% over the past year. The company is forecast to post earnings per share of €4.52 for next year compared to €3.40 last year.
Reported Earnings • Aug 02Second quarter 2024 earnings released: EPS: €0.71 (vs €0.70 in 2Q 2023)Second quarter 2024 results: EPS: €0.71 (up from €0.70 in 2Q 2023). Revenue: €139.9m (up 5.2% from 2Q 2023). Net income: €14.4m (up 100% from 2Q 2023). Profit margin: 10% (up from 5.4% in 2Q 2023). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 02AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024AlzChem Group AG announced that they will report Q3, 2024 results on Nov 07, 2024
Price Target Changed • Jul 30Price target increased by 9.4% to €54.05Up from €49.40, the current price target is an average from 4 analysts. New target price is 9.2% above last closing price of €49.50. Stock is up 159% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €3.40 last year.
New Risk • Jul 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.0% average weekly change).
Price Target Changed • May 15Price target increased by 15% to €49.40Up from €43.10, the current price target is an average from 4 analysts. New target price is 12% above last closing price of €44.00. Stock is up 122% over the past year. The company is forecast to post earnings per share of €4.03 for next year compared to €3.40 last year.
お知らせ • May 09AlzChem Group AG to Report First Half, 2024 Results on Aug 01, 2024AlzChem Group AG announced that they will report first half, 2024 results on Aug 01, 2024
Reported Earnings • May 01First quarter 2024 earnings released: EPS: €1.20 (vs €0.76 in 1Q 2023)First quarter 2024 results: EPS: €1.20 (up from €0.76 in 1Q 2023). Revenue: €153.6m (up 1.4% from 1Q 2023). Net income: €12.2m (up 59% from 1Q 2023). Profit margin: 7.9% (up from 5.1% in 1Q 2023). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €43.50, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 101% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.69 per share.
Declared Dividend • Mar 28Dividend increased to €1.20Dividend of €1.20 is 14% higher than last year. Ex-date: 8th May 2024 Payment date: 10th May 2024 Dividend yield will be 3.2%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (35% earnings payout ratio) and cash flows (23% cash payout ratio). The dividend has increased by an average of 1.5% per year over the past 6 years. However, payments have been volatile during that time. EPS is expected to grow by 40% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Price Target Changed • Mar 07Price target increased by 7.9% to €37.35Up from €34.63, the current price target is an average from 4 analysts. New target price is 25% above last closing price of €30.00. Stock is up 60% over the past year. The company is forecast to post earnings per share of €3.83 for next year compared to €3.40 last year.
Price Target Changed • Mar 04Price target increased by 7.9% to €35.60Up from €33.00, the current price target is an average from 4 analysts. New target price is 31% above last closing price of €27.10. Stock is up 38% over the past year. The company is forecast to post earnings per share of €3.77 for next year compared to €3.40 last year.
Price Target Changed • Dec 05Price target increased by 9.1% to €34.63Up from €31.75, the current price target is an average from 4 analysts. New target price is 40% above last closing price of €24.70. Stock is up 36% over the past year. The company is forecast to post earnings per share of €3.51 for next year compared to €2.96 last year.
お知らせ • Nov 30AlzChem Group AG to Report Q1, 2024 Results on Apr 30, 2024AlzChem Group AG announced that they will report Q1, 2024 results on Apr 30, 2024
Price Target Changed • Nov 10Price target increased by 9.3% to €33.00Up from €30.20, the current price target is an average from 4 analysts. New target price is 42% above last closing price of €23.30. Stock is up 40% over the past year. The company is forecast to post earnings per share of €3.31 for next year compared to €2.96 last year.
New Risk • Oct 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.5% average weekly change).
Reported Earnings • Oct 29Third quarter 2023 earnings released: EPS: €0.85 (vs €0.58 in 3Q 2022)Third quarter 2023 results: EPS: €0.85 (up from €0.58 in 3Q 2022). Revenue: €123.9m (down 15% from 3Q 2022). Net income: €8.61m (up 45% from 3Q 2022). Profit margin: 7.0% (up from 4.1% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 27AlzChem Group AG to Report Fiscal Year 2023 Results on Mar 01, 2024AlzChem Group AG announced that they will report fiscal year 2023 results on Mar 01, 2024
お知らせ • Sep 19AlzChem Group AG to Report Q3, 2023 Results on Oct 26, 2023AlzChem Group AG announced that they will report Q3, 2023 results on Oct 26, 2023
Valuation Update With 7 Day Price Move • Aug 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €22.00, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in Germany. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.19 per share.
New Risk • Aug 04New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 42% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (42% net debt to equity). Dividend is not well covered by cash flows (138% cash payout ratio).
Reported Earnings • Aug 03Second quarter 2023 earnings released: EPS: €0.71 (vs €0.95 in 2Q 2022)Second quarter 2023 results: EPS: €0.71 (down from €0.95 in 2Q 2022). Revenue: €128.5m (down 14% from 2Q 2022). Net income: €7.20m (down 25% from 2Q 2022). Profit margin: 5.6% (down from 6.5% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • May 06First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: EPS: €0.76 (down from €0.76 in 1Q 2022). Revenue: €156.0m (up 19% from 1Q 2022). Net income: €7.67m (flat on 1Q 2022). Profit margin: 4.9% (down from 5.9% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.1%. Earnings per share (EPS) also surpassed analyst estimates by 23%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
お知らせ • May 05AlzChem Group AG to Report First Half, 2023 Results on Aug 03, 2023AlzChem Group AG announced that they will report first half, 2023 results on Aug 03, 2023
Upcoming Dividend • May 05Upcoming dividend of €1.05 per share at 5.5% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. Payout ratio is a comfortable 35% but the company is not cash flow positive. Trailing yield: 5.5%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).
Price Target Changed • Mar 21Price target increased by 8.7% to €29.58Up from €27.20, the current price target is an average from 4 analysts. New target price is 57% above last closing price of €18.85. Stock is down 21% over the past year. The company posted earnings per share of €2.96 last year.
Reported Earnings • Mar 01Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €2.96 (up from €2.72 in FY 2021). Revenue: €566.4m (up 32% from FY 2021). Net income: €30.1m (up 8.9% from FY 2021). Profit margin: 5.3% (down from 6.4% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to €17.85, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 12x in the Chemicals industry in Germany. Total loss to shareholders of 10% over the past three years.
お知らせ • Dec 09AlzChem Group AG, Annual General Meeting, May 11, 2023AlzChem Group AG, Annual General Meeting, May 11, 2023, at 10:00 Central European Standard Time.
Price Target Changed • Nov 16Price target decreased to €26.05Down from €29.43, the current price target is an average from 4 analysts. New target price is 55% above last closing price of €16.85. Stock is down 28% over the past year. The company is forecast to post earnings per share of €2.40 for next year compared to €2.72 last year.
Reported Earnings • Oct 28Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: €0.59 (up from €0.46 in 3Q 2021). Revenue: €145.1m (up 48% from 3Q 2021). Net income: €5.93m (up 27% from 3Q 2021). Profit margin: 4.1% (down from 4.8% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 18%. Earnings per share (EPS) also surpassed analyst estimates by 69%. Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
お知らせ • Oct 27AlzChem Group AG to Report Fiscal Year 2022 Final Results on Feb 28, 2023AlzChem Group AG announced that they will report fiscal year 2022 final results at 9:00 AM, Central European Standard Time on Feb 28, 2023
Price Target Changed • Oct 20Price target decreased to €26.05Down from €29.43, the current price target is an average from 4 analysts. New target price is 73% above last closing price of €15.05. Stock is down 33% over the past year. The company is forecast to post earnings per share of €2.55 for next year compared to €2.72 last year.
Reported Earnings • Jul 27Second quarter 2022 earnings released: EPS: €0.95 (vs €0.90 in 2Q 2021)Second quarter 2022 results: EPS: €0.95 (up from €0.90 in 2Q 2021). Revenue: €142.4m (up 26% from 2Q 2021). Net income: €9.59m (up 4.5% from 2Q 2021). Profit margin: 6.7% (down from 8.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 8.7%, compared to a 7.3% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • May 11First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.76 (down from €0.78 in 1Q 2021). Revenue: €133.5m (up 25% from 1Q 2021). Net income: €7.70m (down 2.4% from 1Q 2021). Profit margin: 5.8% (down from 7.4% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 9.9%. Over the next year, revenue is forecast to grow 8.7%, compared to a 6.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Upcoming Dividend • Apr 29Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 06 May 2022. Payment date: 10 May 2022. Payout ratio is a comfortable 37% and this is well supported by cash flows. Trailing yield: 4.5%. Within top quartile of German dividend payers (4.0%). In line with average of industry peers (4.9%).
Reported Earnings • Feb 25Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: €2.72 (up from €1.94 in FY 2020). Revenue: €433.7m (up 12% from FY 2020). Net income: €27.6m (up 40% from FY 2020). Profit margin: 6.4% (up from 5.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 4.1%, compared to a 6.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS €0.46 (vs €0.37 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €98.1m (up 17% from 3Q 2020). Net income: €4.69m (up 25% from 3Q 2020). Profit margin: 4.8% (up from 4.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Price Target Changed • Aug 09Price target increased to €32.25Up from €28.50, the current price target is an average from 2 analysts. New target price is 31% above last closing price of €24.70. Stock is up 23% over the past year.
Reported Earnings • Aug 06Second quarter 2021 earnings released: EPS €0.66 (vs €0.66 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €113.5m (up 6.5% from 2Q 2020). Net income: €9.17m (up 37% from 2Q 2020). Profit margin: 8.1% (up from 6.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year and the company’s share price has also fallen by 6% per year.
Reported Earnings • May 07First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €108.3m (up 13% from 1Q 2020). Net income: €7.89m (up 80% from 1Q 2020). Profit margin: 7.3% (up from 4.6% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • May 06Upcoming dividend of €0.77 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 18 May 2021. Trailing yield: 3.1%. Within top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).
Reported Earnings • Mar 20Full year 2020 earnings released: EPS €1.94 (vs €1.77 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €389.9m (up 1.3% from FY 2019). Net income: €19.7m (up 9.6% from FY 2019). Profit margin: 5.1% (up from 4.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Feb 25New 90-day high: €24.50The company is up 19% from its price of €20.60 on 27 November 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €43.68 per share.
お知らせ • Jan 16AlzChem Group AG to Report Fiscal Year 2020 Results on Mar 19, 2021AlzChem Group AG announced that they will report fiscal year 2020 results on Mar 19, 2021
Analyst Estimate Surprise Post Earnings • Nov 12Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 16%. Over the next year, revenue is forecast to grow 4.9%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Nov 12Third quarter 2020 earnings released: EPS €0.37The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: €84.1m (down 18% from 3Q 2019). Net income: €3.76m (down 25% from 3Q 2019). Profit margin: 4.5% (down from 4.9% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 78% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
お知らせ • Nov 07AlzChem Group AG Expands Nitrile Production by 50%AlzChem Group AG consistently continues its growth and investment strategy even in the current environment. Due to the continuing high level of market demand, nitrile production will be expanded by up to 50% by the second quarter of 2021. The investment volume amounts to approximately EUR 12 million. The currently available capacities had only been expanded as of July 2019 and quickly reached 100% capacity. The additional nitrile production capacities are intended to primarily support the growth of medications and biocides. AlzChem takes advantage of the market trend towards more robust supply chains, thus following the trend of increased supply security through a European supplier. The expanded nitrile production plant is again based on AlzChem's proven gas phase technology, which is continuously being optimized by AlzChem engineers and chemists and which sets the standards in terms of raw material yield and environmental aspects.
Is New 90 Day High Low • Oct 30New 90-day low: €17.50The company is down 4.0% from its price of €18.15 on 31 July 2020. The German market is also down 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.80 per share.
お知らせ • Oct 15AlzChem Group AG Revises Consolidated Sales Guidance for the Fiscal Year 2020AlzChem Group AG revised consolidated sales guidance for the fiscal year 2020. Due to the continuing economic effects of the COVID-19 pandemic in individual target industries and regions, AlzChem Group AG adjusts its forecast for fiscal year 2020. The company now expects to generate stable to slightly declining consolidated sales compared to the previous year (original forecast: slightly rising to sharply rising).
お知らせ • Oct 01+ 1 more updateAlzChem Group AG to Report First Half, 2021 Results on Aug 05, 2021AlzChem Group AG announced that they will report first half, 2021 results on Aug 05, 2021
お知らせ • Sep 12AlzChem Group AG to Report Q1, 2021 Results on May 06, 2021AlzChem Group AG announced that they will report Q1, 2021 results on May 06, 2021
